Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.

Zhao F, Shang Y, Zeng C, Gao D, Li K.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11579-86. eCollection 2015.

2.
3.

Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.

Sun Y, Tan L, Li H, Qin X, Liu J.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11615-21. eCollection 2015.

4.

Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.

Xue MH, Li GY, Wu XJ, Zhang CX, Zhang CF, Zhu KX.

Int J Clin Exp Pathol. 2015 May 1;8(5):5563-9. eCollection 2015.

5.

Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.

He MG, Zheng K, Tan D, Wang ZX.

Genet Mol Res. 2016 Mar 31;15(1). doi: 10.4238/gmr.15017879.

6.

Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.

Lu B, Li J, Gao Q, Yu W, Yang Q, Li X.

Gene. 2014 May 25;542(1):64-8. doi: 10.1016/j.gene.2014.02.043. Epub 2014 Feb 26.

PMID:
24582975
7.

Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population.

Zhao R, Ying MF.

Genet Mol Res. 2016 Mar 11;15(1):15017263. doi: 10.4238/gmr.15017263.

8.

Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.

Mo J, Luo M, Cui J, Zhou S.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15065-71. eCollection 2015.

9.

The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.

Zhao Z, Zhang A, Zhao Y, Xiang J, Yu D, Liang Z, Xu C, Zhang Q, Li J, Duan P.

Biosci Rep. 2018 Jun 21;38(3). pii: BSR20180114. doi: 10.1042/BSR20180114. Print 2018 Jun 29.

10.

Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.

Sun Y, Wu Y, Li W, Kong Z, Zou X.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):7905-12. eCollection 2015.

11.

Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.

Zheng DL, Tang GD, Chen YN, Zhang T, Qin MB.

Genet Mol Res. 2016 Apr 26;15(2). doi: 10.4238/gmr.15027384.

12.

Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.

Yu H, Wu X, Zhang Y, Jin Z, Li G, Zhao H.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):4106-12. eCollection 2015.

13.

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.

Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, Hamdi K, Cherif M, Ben Slama MR, Sfaxi M, Othman FB, Chebil M, Elgaaied AB, Ouerhani S.

BMC Cancer. 2011 Mar 22;11:101. doi: 10.1186/1471-2407-11-101.

14.

Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.

Cao ZH, Yin HP, Jiang N, Yu B.

Genet Mol Res. 2015 Aug 21;14(3):10145-51. doi: 10.4238/2015.August.21.21.

15.

Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.

Xiao S, Gao L, Liu Y, Yu T, Jin C, Pan L, Zhu G, Lu X.

Mutat Res. 2013 Feb 18;751(1):52-8. doi: 10.1016/j.mrgentox.2012.11.002. Epub 2012 Nov 10.

PMID:
23147699
16.
17.

Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.

Zhou CX, Zhao JH.

Genet Mol Res. 2015 Mar 31;14(1):2868-75. doi: 10.4238/2015.March.31.17. Review.

18.

ERCC1 and ERCC2 variants predict survival in gastric cancer patients.

Li Y, Liu Z, Liu H, Wang LE, Tan D, Ajani JA, Wei QY.

PLoS One. 2013 Sep 2;8(9):e71994. doi: 10.1371/journal.pone.0071994. eCollection 2013.

19.

Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.

Zhou J, Liu ZY, Li CB, Gao S, Ding LH, Wu XL, Wang ZY.

Tumour Biol. 2015 Apr;36(4):3017-23. doi: 10.1007/s13277-014-2936-3. Epub 2014 Dec 28.

PMID:
25542228
20.

Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.

Zhang Q, Lv LY, Li BJ, Zhang J, Wei F.

Genet Mol Res. 2015 Sep 22;14(3):11235-41. doi: 10.4238/2015.September.22.17.

Supplemental Content

Support Center